To further identify the contribution of BMP9 expression in the prognosis of patients with HCC, we divided these 54 patients into two groups based on BMP9 expression in tumor compared with expression in adjacent liver tissue and analyzed overall survival in these two groups. The gene discussed is GDF2; the disease is neoplasm.